Target intelligence / Profile preview

High mobility group nucleosome-binding domain-containing protein (HMGN)

Target
HMGN
Molecular classification
Chromatin architectural protein, Non-histone chromosomal protein, Nucleosome-binding protein, Other (regulator of chromatin structure)
01

Overview

The high mobility group nucleosome-binding domain-containing protein (HMGN) family is a set of small, non-histone chromatin-associated proteins in vertebrates, including HMGN1, HMGN2, HMGN3, HMGN4, and HMGN5[1][3]. These proteins possess a conserved nucleosome-binding domain that mediates interactions with nucleosomes and various nuclear components. HMGN proteins are critical modulators of chromatin structure, reducing chromatin compaction, enhancing transcription from chromatin templates, and facilitating access for DNA repair and other enzymes. They interact with core histones and nucleosomal DNA, often antagonizing the binding or action of the linker histone H1, and participate in regulation of gene expression at the epigenetic level. Expression is ubiquitous across vertebrate tissues, with higher abundance during embryogenesis. Posttranslational modifications (phosphorylation, acetylation, sumoylation) can regulate their affinity for chromatin, and some have specialized functions such as antimicrobial activity (HMGN2). The family as a whole is not a conventional druggable target; research focuses on their fundamental role in chromatin architecture and genome function rather than direct therapeutic intervention[1][3][5][4].

Other names
High mobility group N proteinHMGN proteinnon-histone chromosomal proteinHMG-14/17 (older nomenclature)nucleosome-binding protein
02

Biological functions

Chromatin structure modulationTranscription regulationDNA repair facilitationInfluence on histone posttranslational modificationsArchitectural regulation of chromatin
03

Disease associations

Cancer (some HMGN members implicated in tumor biology)Other (general roles in epigenetic regulation and development; some family members with immune modulation and antimicrobial effects)

Beyond the preview

Go deeper on High mobility group nucleosome-binding domain-containing protein (HMGN).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on High mobility group nucleosome-binding domain-containing protein (HMGN).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call